News Room

Ablatherm HIFU receives approval in Argentina

EDAP TMS just obtained approval from the Minitry of Health in Argentina for Ablatherm HIFU for the minimally-invasive treatment of localized prostate cancer. After being approved in Brazil earlier this year, the approval in Argentina shows that Ablatherm HIFU is gaining acceptance in South America.

Financial news

Please go to Investors information section.